Clinical Trial Update: A Biomarker Screening Protocol for Participants With Solid Tumors

View source ↗

Summary

A clinical trial update describes a biomarker screening protocol for participants with solid tumors, and the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Fallopian Tube Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Peritoneal Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Lyell Immunopharma, Inc. | Conditions: Triple Negative Breast Cancer, Non-small Cell Lung Cancer | Status: TERMINATED